CVS Eyes Specialty Pharmacy Opportunity through Acquisitions
CVS is the largest specialty pharmacy in the United States. Specialty sales came in at $31 billion in 2014 and are expected to rise to $37 billion this year.
Earnings Preview: Key Performance Drivers for CVS Health in 2Q15
CVS Health (CVS) will declare its 2Q15 earnings on August 4. Markets are expecting a solid quarter with consensus Wall Street analyst estimates projecting EPS of $1.196.
LALT: A True Hedge ETF
The PowerShares Multi-Strategy Alternative Portfolio ETF (LALT) is one of those rare alternative ETFs that tries to replicate the performance of its index by active management of its assets.
Alternative ETFs’ Investment Strategy Guide
A liquid alternative ETF, the ProShares Large Cap Core Plus ETF (CSM) tracks a long-short index of Credit Suisse 130/30.
Company & Industry Overviews
CVS Health Issues Most High-Grade Bonds in Week Ended July 17
PepsiCo (PEP) issued high-grade bonds worth $3.25 billion. The A1/A rated bonds were issued via the following five parts.
CVS Goes Shopping: Financing the Target Purchase
CVS Health has been aggressively expanding, announcing its intention to acquire long-term care provider Omnicare in May for $12.7 billion in an all-cash deal.
Blue Ridge Capital Lowered Its Position in Walgreens Boots Alliance
Walgreens Boots Alliance reported that net sales in the second quarter of 2015 increased by 35.5% to $26.6 billion. Q2 earnings increased by 21.6% to $1.18 per share.
Blue Ridge Capital Opens New Position in Walgreens Boots Alliance
Walgreens Boots Alliance is a firm created by the merger of Walgreens and Alliance Boots in December 2014.
Viking Global’s New Position in Walgreens Boots Alliance
Viking Global Investors started a new position in Walgreens Boots Alliance (WBA). The fund bought 18,933,712 shares of Walgreens Boots Alliance.
Iridian slightly raises its holdings in SemGroup Corporation
In its 13G filing, Iridian Asset Management slightly increased its holdings in SemGroup (SEMG). This resulted in a passive stake of 8.2% in the company.
Omnicare gets 18% increase in Iridian
Iridian increased its shares in Omnicare by approximately 18%, from 5,047,158 shares to 5,948,816. The fund holds a 6.1% passive stake in Omnicare.
Iridian boosts holding in Avis Budget Group by 43%
Iridian raised its position in Avis Budget Group, Inc. (CAR) to 5,395,808 shares from 3,773,401, a 43% increase. Iridian has a passive 5.1% stake in Avis.